213 related articles for article (PubMed ID: 37243761)
1. A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms.
Molderings GJ; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2881-2891. PubMed ID: 37243761
[TBL] [Abstract][Full Text] [Related]
2. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
3. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
5. Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.
Elieh Ali Komi D; Bjermer L
Clin Rev Allergy Immunol; 2019 Apr; 56(2):234-247. PubMed ID: 30506113
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 Mimetic Peptide Ac
Oliveira MP; Prates J; Gimenes AD; Correa SG; Oliani SM
Front Immunol; 2021; 12():689484. PubMed ID: 34557187
[TBL] [Abstract][Full Text] [Related]
7. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation.
Parente R; Giudice V; Cardamone C; Serio B; Selleri C; Triggiani M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108232
[TBL] [Abstract][Full Text] [Related]
8. Mast cells in mastocytosis and allergy - Important player in metabolic and immunological homeostasis.
Renke J; Kędzierska-Mieszkowska S; Lange M; Nedoszytko B; Wasilewska E; Liberek A; Renke M; Niedoszytko M; Witkowski J; Skórko-Glonek J; Lipińska B
Adv Med Sci; 2019 Mar; 64(1):124-130. PubMed ID: 30641273
[TBL] [Abstract][Full Text] [Related]
9. Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.
Legere SA; Haidl ID; Légaré JF; Marshall JS
Front Immunol; 2019; 10():580. PubMed ID: 31001246
[TBL] [Abstract][Full Text] [Related]
10. Mast Cell Activation Disease and Microbiotic Interactions.
Afrin LB; Khoruts A
Clin Ther; 2015 May; 37(5):941-53. PubMed ID: 25773459
[TBL] [Abstract][Full Text] [Related]
11. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome.
Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2533-2541. PubMed ID: 32142966
[TBL] [Abstract][Full Text] [Related]
12. Mast Cell Activation and KSHV Infection in Kaposi Sarcoma.
Ayers LW; Barbachano-Guerrero A; McAllister SC; Ritchie JA; Asiago-Reddy E; Bartlett LC; Cesarman E; Wang D; Rochford R; Martin JN; King CA
Clin Cancer Res; 2018 Oct; 24(20):5085-5097. PubMed ID: 30084838
[No Abstract] [Full Text] [Related]
13. Decoding the intricacies of the mast cell compartment.
Carter MC; Metcalfe DD
Br J Haematol; 2022 Jan; 196(2):304-315. PubMed ID: 34374078
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice.
Meurer SK; Neß M; Weiskirchen S; Kim P; Tag CG; Kauffmann M; Huber M; Weiskirchen R
PLoS One; 2016; 11(6):e0158104. PubMed ID: 27337047
[TBL] [Abstract][Full Text] [Related]
15. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis: from a Molecular Point of View.
Komi DEA; Rambasek T; Wöhrl S
Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
[TBL] [Abstract][Full Text] [Related]
17. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
18. Mast cells and mastocytosis.
Söderholm JD
Dig Dis; 2009; 27 Suppl 1():129-36. PubMed ID: 20203509
[TBL] [Abstract][Full Text] [Related]
19. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.
Afrin LB; Dempsey TT; Rosenthal LS; Dorff SR
J Obstet Gynaecol; 2019 Jul; 39(5):664-669. PubMed ID: 30964355
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
